R&D News | pharmaphorum

News

Novo Holdings co-leads $200m financing into Esco Lifescience...

Life sciences tools company Esco Lifesciences Group has scored $200m in a series A and crossover round co-led by Novo Holdings and

News

After Sanofi's setbacks, Takeda eyes finish line with its de...

Takeda has revealed long-term clinical trial results with its dengue vaccine that reinforce its safety and efficacy – and help to differentiate it from Sanofi's challenged Dengvaxia shot.

News

NGM craters after dropping mid-stage NASH candidate aldaferm...

Shares in NGM Biopharma have plummeted after the US biotech said it would abandon development of aldafermin in non-alcoholic steatohepatitis (NASH), adding to a lengthening list of failed c

News

Trial win sets up filings for Lilly's diabetes blockbuster h...

Eli Lilly has scored five out of five with its phase 3 trials of type 2 diabetes candidate tirzepatide, setting up regulatory filings for a drug that the drugmaker thinks could be the lynch

News

Under-pressure GSK sells stake in respiratory diseases partn...

GlaxoSmithKline has sold its entire stake in its respiratory partner Innoviva, raising $392 million and simplifying its business ahead of a split into two.

News

FDA fires broadside at CytoDyn over COVID-19 antibody data

In a rare move, the FDA has publicly accused US biotech CytoDyn of misrepresenting clinical trial results for leronlimab, an antibody being developed for COVID-19.

Novo Holdings co-leads $200m financing into Esco Lifescience...

After Sanofi's setbacks, Takeda eyes finish line with its de...

NGM craters after dropping mid-stage NASH candidate aldaferm...

Trial win sets up filings for Lilly's diabetes blockbuster h...

Under-pressure GSK sells stake in respiratory diseases partn...

FDA fires broadside at CytoDyn over COVID-19 antibody data

Amazon puts $100m into global health drive

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks